Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Oregon Psilocybin Services Act
Deschutes County commissioners send psilocybin ‘opt out’ measure to November ballot - KTVZ
Voters across Deschutes County this fall will decide whether to “opt out” of psilocybin use and production in the unincorporated areas of the county.
Ashland leaders vote to allow manufacture, sale of therapeutic psilocybin - KOBI-TV NBC5 / KOTI-TV NBC2
ASHLAND, Ore. – Tuesday night, the Ashland city council voted “no” on a proposed two-year ban that would keep the therapeutic use of psilocybin out of city limits. The city councilors agreed unanimously to allow the manufacture and sale of psilocybin products within the City of Ashland. Ashland is t…
Oregon therapeutic psilocybin program sparks some confusion
As Oregon drafts the rules for its new psilocybin program, the first of its kind in the U.S., residents are voicing concern about the confusing patchwork of local ordinances that may emerge.
The future of psilocybin in Jackson County
The Jackson County Psilocybin Services Summit held a meeting Friday afternoon at the Buckhorn Springs Resort to talk about the future of psilocybin treatment in Southern Oregon.
Medford eyes magic mushroom ban
Medford might join a growing local movement to ban “magic mushroom” therapy centers in Jackson County.
Medford City Council Thursday will consider a resolution to place a measure on the Nov. 8 ballot ...
Medford City Council Thursday will consider a resolution to place a measure on the Nov. 8 ballot ...
Clackamas County may vote on delay of state psilocybin program
Two-year ban is before the county board, which will decide July 28 whether to put in on the Nov. 8 ballot.
Right to Try
Cory Booker And Rand Paul Bill Would Force DEA To Let Patients Use Psychedelics And Marijuana
Bipartisan and bicameral congressional lawmakers filed companion bills on Wednesday to clarify that federal “Right to Try” (RTT) laws give seriously ill patients access to Schedule I drugs, including marijuana and psychedelics like psilocybin and MDMA. Sens. Cory Booker (D-NJ) and Rand Paul (R-KY),…
Right to Try; Psychedelics in Defense Spending Bill; Updates from Oregon
This week we’re looking at the following developments: Next week, we could see a significant development in the ongoing Right to Try case AIMS et al. Vs. DEA; we’ll look ahead to what this could mean. Two amendments to a U.S. Defense bill include measures to study psychedelics.
Top Senators Introduce Bill Allowing Patients to Use Psychedelics | Microdose
Top senators Cory Booker and Rand Paul introduced a bipartisan bill that would clarify laws and give seriously ill patients access to Schedule I drugs, including marijuana and psychedelics.
Research, Science & Therapy
A single dose of psilocybin has long-lasting antidepressant-like effects in fruit flies
Scientists have taken an important first step into studying the effects of the psychedelic drug psilocybin -- the active substance in “magic” mushrooms -- at a cellular and genetic level. Their findings, published in Scientific Reports, indicate that a single dose of psilocybin produces a long-lasti…
Busines
With Magic Mushrooms, Small Businesses Lead, Hoping Laws Will Follow
It’s hard to miss the bright green banner draped over Vancouver’s Coca Leaf Café that declares: MUSHROOM DISPENSARY.
A Trip Through the Booming Industry of Semi-Psychedelic Products
From psychedelic water to tinctures made with sacred plants from the Amazon, companies are experimenting with legal alternatives to psychedelics.
Field Trip Announces First Dosings in Phase I Clinical Study of FT-104
Field Trip’s first successful administration of a novel dosings in the Phase 1 Clinical Study entitled of FT-104 HCl In Healthy Volunteers.
Culture
Keeping the Hippie Dream Alive
Sound baths, cannabis prayers and sunset howls: DoubleBlind, a California media company, tries to revive the psychedelic spirit for a new generation.
Indigenous Medicine Conservation Fund To Raise $20 Million In Support Of Indigenous-Led ‘Psychedelic’ Projects
A newly launched Indigenous-led non-profit organization wants to help strengthen Indigenous communities’ efforts to preserve their traditional medicines, including ayahuasca, toad, iboga, peyote, and mushrooms; their access to which is being increasingly threatened.
Subscribe
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
